Literature DB >> 2097701

Prediction of antibiotic dosing intervals from in vitro susceptibility, pharmacokinetics and post-antibiotic effect: theoretical considerations.

J D Turnidge1.   

Abstract

Because of the complexity of determining minimum inhibitory concentration (MIC) values on multiple drugs in routine laboratories, susceptibility testing has been designed to generate 2 or 3 broadly-predictive susceptibility categories: susceptible, (intermediate), and resistant. In contrast, recent dosing studies in vivo have shown that for some antibiotics optimum efficacy is best predicted by time above the known MIC and any postantibiotic effect (PAE). It is possible that the optimum dosing interval can be approximated by the sum of the time greater than MIC and the duration of PAE. PAE is known to be related to AUC of drug concentration and time of exposure. Formulae are presented that should make it possible to calculate the optimum dosing interval mathematically by knowing (i) the drug's pharmacological parameters and dose, (ii) the organism's MIC and (iii) the relationship between AUC and PAE for the drug-organism combination. Both (i) and (iii) are predetermined values obtained from studies. For some bacterial species, isolates in the susceptible range have very similar MICs (narrow range) and the MIC is therefore reasonably predictable. However, for other species, the precise MIC needs to be measured to perform the calculations. Examples of the application of these formulae are given.

Mesh:

Substances:

Year:  1990        PMID: 2097701

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  4 in total

1.  Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004.

Authors:  W J Munckhof; G Borlace; J D Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC.

Authors:  W J Munckhof; D Olden; J D Turnidge
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.

Authors:  I B Xue; P G Davey; G Phillips
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.

Authors:  Pierre Vaudaux; Patrice Francois; Carmelo Bisognano; Jacques Schrenzel; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.